WAUCONDA, IL ADDRESS Family Medicine Specialists 431 West Liberty Street Wauconda, IL 60081 847-772-4622
CIS Research in Gurnee, IL are conducting a Heart Failure Study
For more information, fill out the questionnaire below or call us at 847-599-2492
Have You Been Diagnosed with Hypertriglyceridemia or Cardiovascular Disease?
Clinical Investigation Specialists (CIS) is now enrolling for a new hypertriglyceridemia study at our clinic in Gurnee, IL. The trial will research the efficacy of the study drug in treating hypertriglyceridemia or atherosclerotic cardiovascular disease.
For more information on this trial, please fill out the contact form below or give us a call at 847-599-2492.
Have You Been Diagnosed with Psoriatic Arthritis?
Clinical Investigation Specialists (CIS) is now enrolling for a new psoriatic arthritis (PsA) study at clinic locations in Skokie, Schaumburg, and Orland Park.
The purpose of the SOLSTICE study is to see if an investigational medication is safe and effective when it is given to patients with psoriatic arthritis. If you participate in this study, you will be in it for about 14 months (1 year and 2 months).
Do you have Type 2 Diabetes? Are you at an increased risk for heart disease or stroke?
Clinical Investigation Specialists (CIS) is now enrolling for the ACHIEVE-4 clinical research study at our Kenosha clinic. This study is for those with type 2 diabetes who are obese and at an increased risk for heart disease or stroke.
Give us a call today at (262) 925-1280 or fill out the questionnaire below to see if this study might be right for you.
HIGH TRIGLYCERIDES OR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
CIS, Inc. in Gurnee is enrolling now. Please contact 847-599-2492 for more information or fill out questionnaire below.
GOUT FLARES BREAKING YOUR STRIDE?
JOIN OUR RESEARCH!
Do you have gout with high uric acid levels?
Do you want to help us stride ahead in gout research?
Have You Been Diagnosed with Sjogren's?
Clinical Investigation Specialists (CIS) is now enrolling for a new Sjogren's study at clinic locations in Skokie, Schaumburg and Orland Park.
The purpose of the study is to demonstrate clinical efficacy, safety and tolerability of Ianalumab 300mg administered monthly or every 3 months compared to placebo in patients with active Sjogren's syndrome,
You may qualify to participate in a Sjogren's study if:
CIS in Gurnee is currently enrolling individuals who have cardiovascular disease for a study that may reduce cardiovascular risks. If you want to see if you qualify to participate please fill out webform below or call 847-594-2926.